n,n-dimethylarginine has been researched along with Arteriosclerosis in 28 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (14.29) | 18.2507 |
2000's | 23 (82.14) | 29.6817 |
2010's | 1 (3.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Behrmann, A; Bello Arredondo, Y; Brill, LM; Cheng, SL; Kapoor, K; Kovacs, A; Krchma, K; Mead, M; Perera, R; Ramachandran, B; Shao, JS; Smith, C; Towler, DA; Williams, BO | 1 |
Bokura, H; Kobayashi, S; Masuda, J; Nabika, T; Notsu, Y; Suyama, Y; Yamaguchi, S | 1 |
Beaudeux, JL; Cottart, CH; Klimczak, C; Laguillier, C; Nivet-Antoine, V; Sebban, C | 1 |
Arnesen, H; Eid, HM; Eritsland, J; Larsen, J; Seljeflot, I | 1 |
Hörl, WH | 1 |
Cooke, JP; Graf, EE; Kapoor, O; Malinow, MR; Oka, RK; Pachinger, O; Schmölzer, I; Stühlinger, MC; Szuba, A; Upson, BM; Wascher, TC | 1 |
Ritz, E | 1 |
Goligorsky, MS; Sawamura, T; Smirnova, IV | 1 |
Böger, RH | 1 |
Cooke, JP | 2 |
Kurabayashi, M; Morita, H; Nagai, R; Nakamura, T; Saito, Y | 1 |
Hirata, Y | 1 |
Cohen, JJ; Harrington, JT; Hörl, WH; Madias, NE; Zusman, CJ | 1 |
Arnesen, H; Eid, HM; Hjerkinn, EM; Lyberg, T; Seljeflot, I | 1 |
Stanger, O; Stühlinger, MC | 1 |
Böger, RH; Ron, ES | 1 |
Cutrupi, S; Malatino, LS; Mallamaci, F; Tripepi, G; Zoccali, C | 1 |
Li, YJ; Xiong, Y; Yu, XJ | 1 |
Bode-Böger, SM; Böger, RH | 1 |
Cooke, JP; Imaizumi, T; Matsuoka, H; Miyazaki, H; Okuda, S; Ueda, S; Usui, M | 1 |
Barbey, M; Bode-Böger, SM; Böger, RH; Frölich, JC; Kielstein, JT; Koch, KM; Schäffer, J | 1 |
Bode-Böger, SM; Böger, RH; Cooke, JP; Imaizumi, T; Matsuoka, H; Miyazaki, H; Okuda, S; Ueda, S; Usui, M | 1 |
Dillon, MJ; Goonasekera, CD; Rees, DD; Shah, V | 1 |
Bode-Böger, SM; Böger, RH; Frölich, JC; Haller, H; Kielstein, JT | 1 |
Fliser, D; Frölich, JC; Haller, H; Kielstein, JT | 1 |
Balint, RF; Cooke, JP; Her, JH; Kimoto, M; Stühlinger, MC; Tsao, PS | 1 |
Cooke, JP; Losordo, DW | 1 |
13 review(s) available for n,n-dimethylarginine and Arteriosclerosis
Article | Year |
---|---|
[Biology of arterial ageing and arteriosclerosis].
Topics: Adult; Aged; Aging; Arginine; Arteriosclerosis; Atherosclerosis; Calcinosis; Diagnostic Techniques, Cardiovascular; Endothelium, Vascular; Extracellular Matrix; Female; Humans; Hypertension; Lipoproteins; Male; Middle Aged; Monocytes; Osteoblasts; Tunica Media; Vascular Resistance | 2009 |
[Atherosclerosis and uremia: signifance of non-traditional risk factors].
Topics: Arginine; Arteriosclerosis; Homocysteine; Humans; Kidney Failure, Chronic; Oxidative Stress; Phosphates; Prognosis; Risk Factors; Uremia | 2003 |
Atherosclerosis in dialyzed patients.
Topics: Anemia; Animals; Arginine; Arteriosclerosis; Biomarkers; Cause of Death; Comorbidity; Coronary Artery Disease; Diabetes Mellitus; Europe; Humans; Hyperlipidemias; Hypertension; Inflammation; Kidney Failure, Chronic; Mice; Mice, Knockout; Nitric Oxide; Phosphates; Renal Dialysis | 2004 |
[Asymmetrical methylarginine (ADMA) as a cardiovascular risk factor: epidemiological and prospective data].
Topics: Adult; Aged; Aged, 80 and over; Animals; Arginine; Arteriosclerosis; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Cells, Cultured; Child; Coronary Disease; Diabetes Mellitus, Type 2; Disease Models, Animal; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Female; Free Radicals; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Nitric Oxide Synthase; Oxidative Stress; Pre-Eclampsia; Pregnancy; Prospective Studies; Rabbits; Regression Analysis; Renal Dialysis; Risk Factors; Stroke | 2004 |
Asymmetrical dimethylarginine: the Uber marker?
Topics: Amidohydrolases; Arginine; Arteriosclerosis; Biomarkers; Blood Vessels; Endothelium, Vascular; Humans; Nitric Oxide Synthase; Risk Factors; Vascular Resistance | 2004 |
[Involvement of homocysteine in the pathogenesis of hypertension and hypertensive target-organ damage].
Topics: Arginine; Arteriosclerosis; Biopterins; Cell Division; Endothelium, Vascular; Folic Acid; Homocysteine; Humans; Hypertension; Insulin Resistance; Muscle, Smooth, Vascular; Nitric Oxide; Oxidative Stress; Risk Factors | 2004 |
[NO and hypertension].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arginine; Arteriosclerosis; Biopterins; C-Reactive Protein; Endothelium, Vascular; Humans; Hypertension; Mutation; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Perindopril; Reactive Oxygen Species; Vasodilation | 2004 |
The pivotal role of nitric oxide for vascular health.
Topics: Arginine; Arteriosclerosis; Cardiovascular Diseases; Disease Progression; Endothelium, Vascular; Female; Homeostasis; Humans; Male; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Predictive Value of Tests; Risk Factors; Sensitivity and Specificity; Survival Analysis | 2004 |
Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.
Topics: Animals; Arginine; Arteriosclerosis; Endothelium, Vascular; Homocysteine; Humans; Hyperhomocysteinemia; Nitric Oxide; Vascular Diseases | 2005 |
L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor.
Topics: Arginine; Arteriosclerosis; Cardiovascular Diseases; Endothelium, Vascular; Humans; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III | 2005 |
[Endothelial dysfunction in peripheral arterial occlusive disease: from basic research to clinical use].
Topics: Arginine; Arterial Occlusive Diseases; Arteriosclerosis; Endothelium, Vascular; Humans; Nitric Oxide; Vasodilation | 1997 |
Relationship of asymmetric dimethylarginine to dialysis treatment and atherosclerotic disease.
Topics: Arginine; Arteriosclerosis; Biomarkers; Humans; In Vitro Techniques; Kidney Failure, Chronic; Nitric Oxide; Peritoneal Dialysis; Renal Dialysis; Uremia | 2001 |
ADMA (asymmetric dimethylarginine): an atherosclerotic disease mediating agent in patients with renal disease?
Topics: Animals; Arginine; Arteriosclerosis; Enzyme Inhibitors; Humans; Kidney Diseases; Nitric Oxide Synthase | 2001 |
3 trial(s) available for n,n-dimethylarginine and Arteriosclerosis
Article | Year |
---|---|
Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin.
Topics: Arginine; Arteriosclerosis; Cholesterol, LDL; Diabetes Mellitus, Type 1; Female; Humans; Hypercholesterolemia; Incidence; Male; Pravastatin; Predictive Value of Tests; Probability; Reference Values; Risk Assessment; Sensitivity and Specificity | 2003 |
Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine.
Topics: Adult; Age Factors; Aged; Arginine; Arteriosclerosis; Brachial Artery; Endothelium, Vascular; Female; Homocysteine; Homocystine; Humans; Hyperhomocysteinemia; Male; Methionine; Middle Aged; Peripheral Vascular Diseases; Regional Blood Flow; Regression Analysis; Vasodilation | 2003 |
Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease.
Topics: Adult; Aged; Analysis of Variance; Arginine; Arteriosclerosis; Female; Humans; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Prognosis; Reference Values; Renal Dialysis; Severity of Illness Index | 1999 |
12 other study(ies) available for n,n-dimethylarginine and Arteriosclerosis
Article | Year |
---|---|
Vascular smooth muscle LRP6 limits arteriosclerotic calcification in diabetic LDLR-/- mice by restraining noncanonical Wnt signals.
Topics: Animals; Arginine; Arteriosclerosis; Calcinosis; Diabetes Mellitus, Experimental; Dietary Fats; Frizzled Receptors; Gene Expression Regulation; Histones; Low Density Lipoprotein Receptor-Related Protein-6; Male; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Osteopontin; Paracrine Communication; Protein Interaction Mapping; Protein-Arginine N-Methyltransferases; Receptors, Cell Surface; Receptors, LDL; Upstream Stimulatory Factors; Vascular Stiffness; Wnt Signaling Pathway | 2015 |
Evaluation of asymmetric dimethylarginine and homocysteine in microangiopathy-related cerebral damage.
Topics: Arginine; Arteriosclerosis; Biomarkers; Blood Pressure; Brain Damage, Chronic; Cerebral Infarction; Cerebrovascular Disorders; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Homocysteine; Humans; Hypertension; Japan; Magnetic Resonance Imaging; Male; Middle Aged; Nitric Oxide Synthase; Odds Ratio; Regression Analysis; Risk Assessment | 2009 |
Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in endothelial cells by nitric oxide deficiency.
Topics: Arginine; Arteriosclerosis; Blotting, Western; Cell Culture Techniques; Endothelial Cells; Enzyme Inhibitors; Gene Expression Regulation; Humans; Kidney Failure, Chronic; Lipid Metabolism; Nitric Oxide; Nitric Oxide Synthase; Receptors, LDL; Receptors, Oxidized LDL; Reverse Transcriptase Polymerase Chain Reaction; Scavenger Receptors, Class E; Up-Regulation | 2004 |
Atherosclerosis and uremic retention solutes.
Topics: Arginine; Arteriosclerosis; Female; Glomerulosclerosis, Focal Segmental; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Middle Aged; Nitric Oxide; Oxidative Stress; Phosphates; Uremia | 2004 |
Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine.
Topics: Aged; Arginine; Arteriosclerosis; Coronary Disease; Cross-Sectional Studies; Enzyme Inhibitors; Humans; Insulin Resistance; Male; Metabolic Diseases; Middle Aged; Nitric Oxide Synthase; Obesity; Risk Factors; Smoking | 2004 |
Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD.
Topics: Adult; Aged; Arginine; Arteriosclerosis; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Endothelium, Vascular; Female; Heart Failure; Humans; Kidney Failure, Chronic; Male; Middle Aged; Natriuretic Peptide, Brain; Prognosis | 2005 |
Increase of an endogenous inhibitor of nitric oxide synthesis in serum of high cholesterol fed rabbits.
Topics: Animals; Arginine; Arteriosclerosis; Cholesterol, Dietary; Creatine; Lipids; Male; Nitric Oxide; Rabbits | 1994 |
Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis.
Topics: Adult; Aged; Arginine; Arteriosclerosis; Biomarkers; Carotid Artery, Common; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Nitric Oxide Synthase; Risk Factors; Tunica Intima | 1999 |
Is asymmetric dimethylarginine a novel marker of atherosclerosis?
Topics: Arginine; Arteriosclerosis; Biomarkers; Carotid Arteries; Chromatography, High Pressure Liquid; Cyclic GMP; Enzyme Inhibitors; Humans; Nitrates; Nitric Oxide Synthase; Regression Analysis; Stereoisomerism; Tunica Intima | 2000 |
Vascular endothelial cell activation associated with increased plasma asymmetric dimethyl arginine in children and young adults with hypertension: a basis for atheroma?
Topics: Adolescent; Adult; Arginine; Arteriosclerosis; Child; Child, Preschool; Endothelium, Vascular; Female; Glomerular Filtration Rate; Humans; Hypertension; Infant; Male; Vascular Cell Adhesion Molecule-1 | 2000 |
Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine.
Topics: Amidohydrolases; Animals; Aorta; Arginine; Arteriosclerosis; Cattle; Cell Line; Culture Techniques; Endothelium, Vascular; Homocysteine; Hydrolases; Hyperhomocysteinemia; Kinetics; Methionine; Nitric Oxide; Nitric Oxide Synthase; Recombinant Fusion Proteins; Signal Transduction | 2001 |
Nitric oxide and angiogenesis.
Topics: Angiogenesis Inhibitors; Angiostatins; Animals; Arginine; Arteriosclerosis; Coronary Circulation; Dogs; Endothelium, Vascular; Matrix Metalloproteinases; Myocardial Ischemia; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Plasminogen | 2002 |